These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24618733)

  • 1. Functional and genetic aberrations of in vitro-cultured marrow-derived mesenchymal stromal cells of patients with classical Philadelphia-negative myeloproliferative neoplasms.
    Avanzini MA; Bernardo ME; Novara F; Mantelli M; Poletto V; Villani L; Lenta E; Ingo DM; Achille V; Bonetti E; Massa M; Campanelli R; Fois G; Catarsi P; Gale RP; Moretta A; Aronica A; Maccario R; Acquafredda G; Lisini D; Zecca M; Zuffardi O; Locatelli F; Barosi G; Rosti V;
    Leukemia; 2014 Aug; 28(8):1742-5. PubMed ID: 24618733
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombosis in the Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
    Sankar K; Stein BL; Rampal RK
    Cancer Treat Res; 2019; 179():159-178. PubMed ID: 31317487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetics might elucidate the etiology of acute transformation of chronic myeloproliferative syndromes without a Philadelphia chromosome. A brief report from a multicenter study by the Group Français de Cytogénétique Hématologique.
    Eur J Haematol; 1989 Jul; 43(1):86-7. PubMed ID: 2670606
    [No Abstract]   [Full Text] [Related]  

  • 4. Isochromosome 17q in two cases of acute blast transformation in myeloproliferative disorders.
    McDermott A; Romain D; Fraser ID; Scott GL
    Hum Genet; 1978 Dec; 45(2):215-8. PubMed ID: 738722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow mesenchymal stromal cells of patients with myeloproliferative disorders do not carry the JAK2-V617F mutation.
    Mercier F; Monczak Y; François M; Prchal J; Galipeau J
    Exp Hematol; 2009 Mar; 37(3):416-20. PubMed ID: 19135773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion.
    Jootar S; Pornprasertsud N; Petvises S; Rerkamnuaychoke B; Disthabanchong S; Pakakasama S; Ungkanont A; Hongeng S
    Leuk Res; 2006 Dec; 30(12):1493-8. PubMed ID: 16839603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular markers for the diagnosis of Philadelphia chromosome negative myeloproliferative disorders.
    Klippel S; Pahl HL
    Pathol Biol (Paris); 2004 Jun; 52(5):267-74. PubMed ID: 15217712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The first report of a Philadelphia chromosome and BCR/ABL rearrangement positive myeloproliferative disorder in a child with thrombocythemia.
    Anguita E; Valverde F; González FA; Gil C; Mateo M; Ferro MT; Villegas A
    Leukemia; 1998 Mar; 12(3):442-4. PubMed ID: 9529142
    [No Abstract]   [Full Text] [Related]  

  • 9. Stem cell defects in Philadelphia chromosome negative chronic myeloproliferative disorders: a phenotypic and molecular puzzle?
    Bock O; Hussein K; Kreipe H
    Curr Stem Cell Res Ther; 2007 Sep; 2(3):253-63. PubMed ID: 18220909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis.
    Rambaldi B; Diral E; Donsante S; Di Marzo N; Mottadelli F; Cardinale L; Dander E; Isimbaldi G; Pioltelli P; Biondi A; Riminucci M; D'Amico G; Elli EM; Pievani A; Serafini M
    Ann Hematol; 2021 Jan; 100(1):105-116. PubMed ID: 33089365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of shelterin factors coupled with telomere shortening in Philadelphia chromosome negative myeloproliferative neoplasms.
    Dahlström J; Zhang X; Ghaderi M; Hultcrantz M; Björkholm M; Xu D
    Haematologica; 2015 Oct; 100(10):e402-5. PubMed ID: 26185173
    [No Abstract]   [Full Text] [Related]  

  • 12. [Marker chromosome in myeloproliferative syndrome].
    Fleischmann T; Krizsa F
    Orv Hetil; 1975 Feb; 116(6):326-7. PubMed ID: 1110840
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytogenetics of acutely transformed chronic myeloproliferative syndromes without a Philadelphia chromosome. A multicenter study of 55 patients. Groupe Français de Cytogénétique Hématologique.
    Cancer Genet Cytogenet; 1988 Jun; 32(2):157-68. PubMed ID: 3163258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathogenesis of myeloproliferative syndromes.
    Adamson JW; Fialkow PJ
    Br J Haematol; 1978 Mar; 38(3):299-303. PubMed ID: 346048
    [No Abstract]   [Full Text] [Related]  

  • 15.
    Wong WJ; Hasserjian RP; Pinkus GS; Breyfogle LJ; Mullally A; Pozdnyakova O
    Haematologica; 2018 Feb; 103(2):e63-e68. PubMed ID: 29146710
    [No Abstract]   [Full Text] [Related]  

  • 16. The JAK2 V617F mutation is frequently present in buccal swabs from patients suffering from Philadelphia-negative chronic myeloproliferative disorders, who carry the mutation detected in bone marrow or peripheral blood cells [corrected].
    Stój A; Rudzki Z; Stachura J; Sacha T; Czekalska S
    J Clin Pathol; 2007 Sep; 60(9):1070-1. PubMed ID: 17761748
    [No Abstract]   [Full Text] [Related]  

  • 17. Dynamics of telomere's length and telomerase activity in Philadelphia chromosome negative myeloproliferative neoplasms.
    Spanoudakis E; Bazdiara I; Pantelidou D; Kotsianidis I; Papadopoulos V; Margaritis D; Xanthopoulidis G; Moustakidis E; Mantzourani S; Bourikas G; Tsatalas C
    Leuk Res; 2011 Apr; 35(4):459-64. PubMed ID: 20828816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do current response criteria in classical Ph-negative myeloproliferative neoplasms capture benefit for patients?
    Barosi G; Tefferi A; Barbui T;
    Leukemia; 2012 May; 26(5):1148-9. PubMed ID: 22105597
    [No Abstract]   [Full Text] [Related]  

  • 19. Marker chromosome in myeloproliferative syndrome.
    Fleischmann T; Krizsa F
    Acta Haematol; 1975; 54(1):59-63. PubMed ID: 808080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms.
    Yung Y; Lee E; Chu HT; Yip PK; Gill H
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33440869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.